Speaker(s): 

Maria Camila Bermudez, MD, Associate Program Director Nephrology Fellowship, Director of Home Dialysis, Geisinger Medical Center - has nothing to disclose.

Moderator(s): 

Daniel O. Huston, DNP, RN, Health Manager Lead, Geisinger Wellness Program - Steele Institute - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe how glucose absorption from peritoneal dialysis solutions can be predicted and estimated, and how this information can be used to optimize diabetic management and improve glycemic control in patients with diabetes on peritoneal dialysis. 

• To gain a comprehensive understanding of peritoneal dialysis modality, including its intricacies, benefits, and challenges, and how it impacts diabetic management, in order to provide informed and effective diabetes education and support to patients with diabetes on peritoneal dialysis.  

• To provide healthcare providers with practical strategies and best practices for managing diabetes in patients on dialysis, including glucose monitoring, medication management, and collaboration between nephrologists and diabetes providers. 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Esherick, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH; Dan Huston, DNP, RN and Joey Underhill have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None